Your browser doesn't support javascript.
loading
MALAT1-related signaling pathways in colorectal cancer.
Xu, Wen-Wen; Jin, Jin; Wu, Xiao-Yu; Ren, Qing-Ling; Farzaneh, Maryam.
Afiliación
  • Xu WW; Department of Gynaecology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing , 210029, Jiangsu, China.
  • Jin J; Department of Gynaecology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing , 210029, Jiangsu, China.
  • Wu XY; Department of Surgical Oncology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, China. wuxiaoyu@medmail.com.cn.
  • Ren QL; Department of Gynaecology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing , 210029, Jiangsu, China. m13773222054@163.com.
  • Farzaneh M; Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Cancer Cell Int ; 22(1): 126, 2022 Mar 19.
Article en En | MEDLINE | ID: mdl-35305641
Colorectal cancer (CRC) is one of the most lethal and prevalent solid malignancies worldwide. There is a great need of accelerating the development and diagnosis of CRC. Long noncoding RNAs (lncRNA) as transcribed RNA molecules play an important role in every level of gene expression. Metastasis-associated lung adenocarcinoma transcript-1 (MALAT1) is a highly conserved nucleus-restricted lncRNA that regulates genes at the transcriptional and post-transcriptional levels. High expression of MALAT1 is closely related to numerous human cancers. It is generally believed that MALAT1 expression is associated with CRC cell proliferation, tumorigenicity, and metastasis. MALAT1 by targeting multiple signaling pathways and microRNAs (miRNAs) plays a pivotal role in CRC pathogenesis. Therefore, MALAT1 can be a potent gene for cancer prediction and diagnosis. In this review, we will demonstrate signaling pathways associated with MALAT1 in CRC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: China
...